APW
NVNO

Allied Private Wealth’s enVVeno Medical NVNO Stock Holding History

Allied Private Wealth’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978 Buy
+88
New +$948 ﹤0.01% 812

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allied Private Wealth's NVNO Position: Q2 2026 in Review

Allied Private Wealth opened a new position in enVVeno Medical (NVNO) in Q2 2026: 88 shares worth $978. The stake represents ﹤0.01% of the portfolio and ranks #812 among its holdings.

17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • Allied Private Wealth held 88 shares of enVVeno Medical worth $978 as of Q2 2026.
  • enVVeno Medical was a new Allied Private Wealth position in Q2 2026.
  • enVVeno Medical made up ﹤0.01% of Allied Private Wealth's portfolio in Q2 2026, its #812 holding.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.